Government Digital Service
UK regulatory agency ensuring medicines, medical devices and blood components meet standards of safety, quality and efficacy, from clinical trials to post-market surveillance.
The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK's sovereign agency responsible for ensuring that medicines, medical devices, and blood components for transfusion meet standards of safety, quality, and efficacy. Founded in 2003, it employs over 1,300 staff across sites in London (Canary Wharf) and Leeds, and its work supports the health of millions of people every day.
Its remit spans the regulation of medicines throughout their lifecycle, from clinical trials and market authorization to post-market surveillance and safety monitoring. Technical domains include regulatory science, pharmacovigilance and post-market safety surveillance, clinical trials regulation, medical devices regulation, blood and organ donation regulation, market authorization, and safety and efficacy assessment. Medical devices available in the UK are assessed for safety, quality assurance, and effectiveness.
The agency also operates accelerated access pathways designed to support innovation in the UK's life sciences sector by facilitating early access to safe and innovative medicines while maintaining robust safety standards, alongside the regulation of blood components for transfusion and organ donation. Its work is underpinned by science and research and is directed at protecting public health, balancing innovation enablement with patient safety.